Anchorage-independent colony growth of pulmonary fibroblasts derived from fibrotic human lung tissue

Journal of Clinical Investigation

Volumn 93, Issue 4, 1994, Pages 1525-1532

  Torry, Diane J ^a   Richards, Carl D ^a   Podor, Thomas J ^a   Gauldie, Jack ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

fibroblast heterogeneity; idiopathic pulmonary fibrosis; inflammation; soft agarose growth

Indexed keywords

ALPHA ACTIN; BETA ACTIN; BLOOD CLOTTING FACTOR 8; CORTICOSTEROID; CYTOKINE; DESMIN; DEXAMETHASONE; FIBRONECTIN; KERATIN; LAMININ; PLATELET DERIVED GROWTH FACTOR; TENASCIN; TRANSFORMING GROWTH FACTOR BETA; TROPOMYOSIN; VIMENTIN;

ADULT; ANCHORAGE INDEPENDENT GROWTH; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; COLONY FORMATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IDIOPATHIC DISEASE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LUNG FIBROBLAST; LUNG FIBROSIS; NEWBORN; PRIORITY JOURNAL;

EID: 0028354745     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI117131     Document Type: Article

References (46)

1. Basset, F., V. J. Fenans, P. Soler, T. Takemura, Y. Fukuda, and R. G. Crystal. 1986. Intraluminal fibrosis in interstitial lung disorders. Am. J. Pathol. 122:443-461.
2. Katzenstein, A. L. 1985. Pathogenesis of "fibrosis" in interstitial pneumonia: an electron microscopy study. Hum. Pathol. 16:1015-1024.
3. Madri, J. A., and H. Furthmayr. 1980. Collagen polymorphism in the lung: an immunohistochemical study of pulmonary fibrosis. Hum. Pathol 11:353-366.
4. Kavlinsky, J. B. 1982. Glycosaminoglycans in emphysematous and fibrotic hamster lungs. Am. Rev. Respir. Dis. 125:85-86.
5. Starcher, B. C., C. Kuhn, and J. E. Overton. 1978. Increased elastin and collagen content of the lungs of hamster receiving an intratracheal injection of bleomycin. Am. Rev Respir. Dis. 117:299-305.
6. Bateman, E. D., M. Turner-Warwick, and B. C. Adelmann-Grill. 1981. Immunohistochemical study of collagen types in human foetal lung and fibrotic lung disease. Thorax 36:645-653.
7. Dunnill, M. S. 1990. Pulmonary Fibrosis. Histopathology (Oxf.). 16:321-329.
8. Kuhn, C., J. Boldt, T. E. King, E. Crouch, T. Vartio, and J. A. McDonald. 1989. An immunohistochemical study of architectural remodeling and connective tissue synthesis in pulmonary fibrosis. Am. Rev. Respir. Dis 140:1693-1703.
9. Crystal, R. G., P. B. Bitterman, S. I. Rennard, A. J. Hance, and B. A. Keogh. 1984. Interstitial lung diseases of unknown cause: disorders characterized by chronic inflammation of the lower respiratory tract. N. Engl. J. Med. 310:154-166.
10. Jordana, M., G. Cox, T. Ohtoshi, X. Zhou, J. Dolovich, J. Denburg, and J. Gauldie. 1991. The TDR' concept in chronic airways inflammation: tissue driven response. In Clinical Impact of the Monitoring of Allergic Inflammation. P. Matson, S. Ahlstedt. P. Venge, and J. Thorell, editors. Academic Press Limited, London. 33-46.
11. Gauldie, J., M. Jordana, G. Cox, T. Ohtoshi, J. Dolovich, and J. Denburg. 1992. Fibroblasts and other structural cells in airway inflammation. Am. Rev Respir Dis. 145-.S14-S17.
12. Uitto, J., E. A. Bauer, and A. Z. Eisen. 1979. Increased biosynthesis of triple-helical type I and type III procollagens associated with unaltered expression of collagenase by skin fibroblasts in culture. J. Clin. Invest. 64:921-930.
13. Raghu, G., Y. Chen, V. Rusch, and P. S. Rabinovitch. 1988. Differential proliferation of fibroblasts cultured from normal and fibrotic human lungs. Am. Rev. Respir. Dis. 138:703-708.
14. Bordin, S., R. C. Page, and A. S. Narayanan. 1984. Heterogeneity of normal human diploid fibroblasts: isolation and characterization of one phenotype. Science (Wash. DC). 223:171-173.
15. - lung fibroblast subpopulations. Am. J. Physiol. 263:L283-L290.
16. Jordana, M., J. Schulman, C. McSharry, L. B. Irving, M. T. Newhouse, G. Jordana, and J. Gauldie. 1988. Heterogeneous proliferative characteristics of human adult lung fibroblast lines and clonally derived fibroblasts from control and fibrotic tissue. Am. Rev. Respir. Dis. 137:579-584.
17. Jordana, M., H. Kirpalani, and J. Gauldie. 1992. Heterogeneity of human lung fibroblast proliferation in relation to disease expression. In Pulmonary Fibroblast Heterogeneity. R. P. Phipps, editor. CRC Press, Boca Raton, Inc., FL. 229-249.
18. Kelley J. 1992. Transforming growth factor-β. In Cytokines in the Lung. J. Kelley. editor. Marcel Dekker, Inc., New York. 101-138.
19. Fabisiak, J. P., and J. Kelley. 1992. Platelet-derived growth factor. In Cytokines in the Lung. J. Kelley, editor. Marcel Dekker, Inc., New York. 3-37.
20. Antoniades, H. N., M. A. Bravo, R. E. Avila, T. Galanopoulos, J. Neville-Golden, M. Maxwell, and M. Selman. 1990. Platelet-derived growth factor in idiopathic pulmonary fibrosis. J. Clin. Invest. 80:1055-1064.
21. Martinet, Y., W. N. Rom, G. R. Grotendorst, G. R. Martin, and R. G. Crystal. 1987. Exaggerated spontaneous release of platelet-derived growth factor by alveolar macrophages from patients with idiopathic pulmonary fibrosis. N. Engl. J. Med. 317:202-209.
22. Khalil, N., R. N. O'Connor, H. W. Unruh, P. W. Warren, K. C. Flanders. A. Kemp, O. H. Bereznay, and A. H. Greenberg. 1991. Increased production and immunohistochemical localization of transforming growth factor in idiopathic pulmonary fibrosis. Am. J Respir. Cell Mol. Biol. 5:155-162.
23. Broekelmann, T. J., A. H. Limper, T. V. Colby, and J. A. McDonald. 1991. Transforming growth factor β1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. Proc. Natl. Acad. Sci. USA. 88:6642-6646.
24. Lafyatis, R., E. F. Remmers, A. B. Roberts, D. E. Yocum, M. B. Sporn, and R. L. Wilder. 1989. Anchorage-independent growth of synoviocytes from arthritic and normal joints: stimulation by Exogenous platelet-derived growth factor and inhibition by transforming growth factor-beta and retinoids. J. Clin. Invest. 83:1267-1276.
25. Hirte, H. W. 1993. A quantitative colony-forming bioassay for transforming growth factor-β using a colorimetric endpoint. Proc. Am. Assoc. Cancer Res. 34:1429 (Abstr.).
26. Rhodin, Johannes A. G. 1974. Connective Tissue. In Histology, a Text and Atlas. Oxford University Press, London. 140-171, 348.
27. Goldman, R. D., E. Lazarides, R. Pollack, and K. Weber. 1975. The distribution of actin in non-muscle cells: the use of actin antibody in the localization of actin within the microfilament bundles of mouse 3T3 cells. Exp. Cell Res. 90:333-344.
28. Kirkwood, T. B. L., and R. Holliday. 1975. Commitment to Senescence: a Model for the finite and infinite growth of diploid and transformed human fibroblasts in culture. J. Theor. Biol. 53:481-496.
29. Jones, R. B., and J. R. Smith. 1982. A stochastic model of cellular senescence. II. Concordance with experimental data. J Theor. Biol. 96:443-460.
30. Franke, W. W., B. Appelhans, E. Schmid, C. Freudenstein, M. Osborn, and K. Weber. 1979. Identification and characterization of epithelial cells in mammalian tissues by immunofluorescence microscopy using antibodies to prekeratin. Differentiation. 15.7-25.
31. Franke, W. W., C. Grund, C. Kuhn, B. W. Jackson, and K. Illmensee. 1982. Formation of cytoskeletal elements during mouse embryogenesis III. Primary mesenchymal cells and the first appearance of vimentin filaments. Differentiation. 23:43-59.
32. Podor, T. J., J. I. Weitz, J. Hirsh, D. Seiffert, and D. J. Luskutoff. 1994. Vitronectin-mediated binding of type 1 plasminogen activator inhibitor to vimentin intermediate filaments in damaged endothelial cells: potential mechanism for regulating plasmin generation during the inflammatory process. J. Clin. Invest. In press.
33. Darby, I., O. Skalli, and G. Gabbiani. 1990. α-smooth muscle actin is transiently expressed by myofibroblasts during experimental wound healing. Lab. Invest. 63:21-29.
34. Gabbiani, G., G. B. Ryan, and G. Majno. 1971. Presence of modified fibroblasts in granulation tissue and their possible role in wound contraction. Experientia (Basel). 27:549-550.
35. Kuhn, C, and J. A. McDonald. 1991. The roles of the myofibroblast in idiopathic pulmonary fibrosis: ultrastructural and immunohistochemical features of sites of active extracellular matrix synthesis. Am J. Pathol. 138:1257-1265.
36. Roche, W. R., R. Beasley, J. H. Williams, and S. T. Holgate. 1989. Subepithelial fibrosis in the bronchi of asthmatics. Lancet. ii:520-524.
37. Sims, D. E. 1991. Recent advances in pericyte biology: implications for health and disease. Can. J. Cardiol. 7:431-443.
38. Shepro, D., and N. M. L. Morel. 1993. Pericyte physiology. FASEB (Fed. Am. Soc. Exp. Biol.) J. 7:1031-1038.
39. Mackie, E. J., W. Halfter, and D. Liverani. 1988. Induction of tenascin in healing wounds. J. Cell Biol. 107:2757-2767.
40. Chiquet-Ehrismann, R., E. J. Mackie, C. A. Pearson, and T. Sakakura. 1986. Tenascin: an extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis. Cell. 47:131-139.
41. Skalli, O., M. F. Pelte, M. C. Peclet, G. Gabbiani, P. Gugliotta, G. Bussolati, M. Ravazzola, and L. Orci. 1989. α-smooth muscle actin, a differentiation marker of smooth muscle cells, is present in microfilamentous bundles of pericytes. J. Histochem. Cytochem. 37:315-321.
42. Clark, A. F. 1990. Fibronectin matrix deposition and fibronectin receptor expression in healing and normal skin. J. Invest. Dermatol. 94:128S-134S.
43. Grinnell, F., K. Toda, and A. Takashima. 1987. Activation of keratinocyte fibronectin receptor function during cutaneous wound healing. J. Cell Sci. Suppl. 8:199-209.
44. Wilder, R. L., R. Lafyatis, A. B. Roberts, J. P. Case, G. K. Kumkumian, H. Sano, M. B. Sporn, and E. F. Remmers. 1990. Transforming growth factor-β in Rheumatoid Arthritis. Ann. NY Acad. Sci. 593:197-207.
45. Goddard, D. H. 1992. Regulation of synovial cell growth by polypeptide growth factors. DNA Cell Biol. 11:259-263.
46. Remmers, E. F., J. Sano, R. Lafyatis, J. P. Case, G. K. Kumkumian, T. Hla, T. Maciag, and R. L. Wilder. 1991. Production of platelet derived growth factor β chain (PDGF-B/c-sis) mRNA and immunoreactive PDFG B-like polypeptide by rheumatoid synovium: coexpression with heparin binding acidic fibroblast growth factor-1. J. Rheumatol. 18:7-13.